On October 9th J-Link will visit Bio Japan congress in Yokohama, Japan. Bio Japan is Asia’s Premier Partnering Event for the Global Biotechnology Industry. It has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating new business opportunities. The Japanese and global biotechnology industry’s top business development and licensing professionals, alliance management professionals, R&D personnel and biotech company executives will gather in Yokohama for Bio Japan.
On the 17th of October Complex Cardiovascular Therapeutics (CCT) congress will be held in Kobe, Japan. CCT 2013 will provide the highest quality of cardiovascular care, either percutaneous transcatheter or surgical, for the patients with coronary, structural, heart diseases and peripheral vascular diseases. It is the congress’ mission that has always emphasized and focused on advancement and refinement of the technical approaches and skills for a higher success rate and safer procedures to treat complex, difficult and most challenging cases in Cardiovascular and Peripheral fields. J-Link will participate in this congress to get insight and information on cutting edge technologies that will change interventional cardiology and peripheral procedures in the future.